Hyphens Pharma International Ltd. (SG:1J5) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Hyphens Pharma International Ltd. reported a 22.1% increase in revenue for the first nine months of 2024, reaching S$143.5 million, driven by strong sales in Singapore and Malaysia. Despite a 12.1% rise in gross profit for the third quarter, net profit after tax slightly declined due to increased distribution and administrative costs. The company remains optimistic about its financial growth, bolstered by favorable currency exchange rates.
For further insights into SG:1J5 stock, check out TipRanks’ Stock Analysis page.